Super-Sharp brain scanner could revolutionize diagnosis of dementia and cancer
NCT ID NCT07595666
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new ultra-high resolution PET/CT scanner, the NeuroEXPLORER, with standard clinical PET/CT scanners for imaging the head and neck. Researchers aim to see if the new device provides more detailed images to improve diagnosis of conditions like dementia, Parkinson's disease, brain tumors, and head and neck cancers. About 1,600 participants will receive both scans in one visit, and their images will be compared for accuracy and diagnostic confidence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this scanner could provide clearer, more detailed images to help doctors diagnose and monitor brain and neck conditions more accurately.
- What could go wrong
- This is an early-stage device comparison study, not a treatment trial. The new scanner may not prove significantly better in practice, and its benefits may be limited to certain conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS - AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZ Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your brain help unlock Alzheimer's secrets?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a gene therapy clear the toxic tau tangle in Alzheimer's?
- Can a Dual-Pronged antibody outsmart advanced solid tumors?
- Can a Voice-Based app map healthy brain aging across 80 years?